These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 2173717)
21. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF. Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985 [TBL] [Abstract][Full Text] [Related]
22. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation. Donato NJ; Ince C; Rosenblum MG; Gallick GE J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis. Corrigall VM; Bodman-Smith MD; Brunst M; Cornell H; Panayi GS Arthritis Rheum; 2004 Apr; 50(4):1164-71. PubMed ID: 15077298 [TBL] [Abstract][Full Text] [Related]
24. Prostaglandin-E2 regulation of tumor necrosis factor receptor release in human monocytic THP-1 cells. Choi SS; Gatanaga M; Granger GA; Gatanaga T Cell Immunol; 1996 Jun; 170(2):178-84. PubMed ID: 8660816 [TBL] [Abstract][Full Text] [Related]
25. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. Pocsik E; Mihalik R; Penzes M; Loetscher H; Gallati H; Aggarwal BB J Cell Biochem; 1995 Nov; 59(3):303-16. PubMed ID: 8567749 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor: receptors and inhibitors. Loetscher H; Steinmetz M; Lesslauer W Cancer Cells; 1991 Jun; 3(6):221-6. PubMed ID: 1654969 [TBL] [Abstract][Full Text] [Related]
28. Purification of type I and type II tumor necrosis factor receptors from human lung tissue. Abdolrasulnia R; Shepherd VL Am J Respir Cell Mol Biol; 1992 Jul; 7(1):42-8. PubMed ID: 1320902 [TBL] [Abstract][Full Text] [Related]
29. [TNF: antitumoral agent at the border lines of immunity and inflammation]. Branellec D; Chouaib S Pathol Biol (Paris); 1991 Mar; 39(3):230-9. PubMed ID: 1646993 [TBL] [Abstract][Full Text] [Related]
31. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. Digel W; Porzsolt F; Schmid M; Herrmann F; Lesslauer W; Brockhaus M J Clin Invest; 1992 May; 89(5):1690-3. PubMed ID: 1314854 [TBL] [Abstract][Full Text] [Related]
32. A tumor necrosis factor binding protein is present in human biological fluids. Peetre C; Thysell H; Grubb A; Olsson I Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215 [TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of liposomal-lipophilic tumor necrosis factor. Utsumi T; Hung MC; Klostergaard J Cancer Res; 1991 Jul; 51(13):3362-6. PubMed ID: 2054776 [TBL] [Abstract][Full Text] [Related]
34. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein. Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293 [TBL] [Abstract][Full Text] [Related]
35. Modulation of two forms of tumor necrosis factor receptors and their cellular response by soluble receptors and their monoclonal antibodies. Higuchi M; Aggarwal BB J Biol Chem; 1992 Oct; 267(29):20892-9. PubMed ID: 1328214 [TBL] [Abstract][Full Text] [Related]
36. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors. Yoshie O; Tada K; Ishida N J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of ligand binding and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of recombinant P60 and P80 receptors. Higuchi M; Aggarwal BB Biochem Biophys Res Commun; 1992 Jan; 182(2):638-43. PubMed ID: 1310388 [TBL] [Abstract][Full Text] [Related]
38. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. Lantz M; Thysell H; Nilsson E; Olsson I J Clin Invest; 1991 Dec; 88(6):2026-31. PubMed ID: 1752960 [TBL] [Abstract][Full Text] [Related]
39. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship. Zhang XM; Weber I; Chen MJ J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of tumor necrosis factor (TNF) sensitivity via modulation of TNF binding capacity by protein kinase C activators. Unglaub R; Maxeiner B; Thoma B; Pfizenmaier K; Scheurich P J Exp Med; 1987 Dec; 166(6):1788-97. PubMed ID: 2824656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]